Cargando…
TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
Immunotherapies that can either activate or suppress innate immune responses are being investigated as treatments against infectious diseases and the pathology they can cause. The objective of these therapies is to elicit protective immune responses thereby limiting the harm inflicted by the pathoge...
Autores principales: | Mifsud, Edin J., Tan, Amabel C. L., Jackson, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939722/ https://www.ncbi.nlm.nih.gov/pubmed/24624130 http://dx.doi.org/10.3389/fimmu.2014.00079 |
Ejemplares similares
-
Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam(2)Cys
por: Mifsud, Edin Jessica, et al.
Publicado: (2015) -
GLP-1 receptor agonist as a modulator of innate immunity
por: Chen, Jun, et al.
Publicado: (2022) -
Modulation of Innate Immune
Responses via Covalently
Linked TLR Agonists
por: Tom, Janine K., et al.
Publicado: (2015) -
Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy
por: Poulas, Konstantinos, et al.
Publicado: (2020) -
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)